Found: 14
Select item for more details and to access through your institution.
Dasiglucagon, a next‐generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double‐blind trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2329, doi. 10.1111/dom.14475
- By:
- Publication type:
- Article
Lack of systematically found insulin autoantibodies in spontaneously diabetic BB rats.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Nonprogression of Subclinical β-Cell Dysfunction Among First-Degree Relatives of IDDM Patients.
- Published in:
- Diabetes, 1990, v. 39, n. 5, p. 549, doi. 10.2337/diab.39.5.549
- By:
- Publication type:
- Article
β-Cell Function and Insulin Sensitivity in Nondiabetic HLA-Identical Siblings of Insulin-Dependent Diabetics.
- Published in:
- Diabetes, 1987, v. 36, n. 7, p. 829, doi. 10.2337/diab.36.7.829
- By:
- Publication type:
- Article
Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia.
- Published in:
- 1987
- By:
- Publication type:
- journal article
346-P: Predicting True Time to Recovery from Insulin-Induced Hypoglycemia with Dasiglucagon.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-346-P
- By:
- Publication type:
- Article
345-P: The Next Generation Glucagon Analog Dasiglucagon Consistently Achieves Rapid Recovery from Hypoglycemia across Subgroups.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-345-P
- By:
- Publication type:
- Article
344-P: Integrated Safety Analysis of Dasiglucagon for Treatment of Severe Hypoglycemia.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-344-P
- By:
- Publication type:
- Article
236-OR: Volagidemab, a Human Glucagon Receptor Antagonist, Improves Glycemic Control in Subjects with Type 1 Diabetes (T1D): A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-236-OR
- By:
- Publication type:
- Article
232-OR: Long-Term Safety and Efficacy of Ultra-Rapid Lispro (URLi) in PRONTO-T1D.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-232-OR
- By:
- Publication type:
- Article
1053-P: Dasiglucagon Hypopal Autoinjector as a Fast and Effective Treatment for Severe Hypoglycemia: Results of a Phase 3 Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1053-P
- By:
- Publication type:
- Article
171-LB: A Pilot Study to Evaluate the Utility of an Interconnected Diabetes Management Solution in People with T2D.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-171-LB
- By:
- Publication type:
- Article
144-OR: Ultra Rapid Lispro (URLi) Improves Postprandial Glucose (PPG) Control vs. Humalog (Lispro) in T1D: PRONTO-T1D Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-144-OR
- By:
- Publication type:
- Article
Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes.
- Published in:
- Diabetes Care, 2010, v. 33, n. 6, p. 1173, doi. 10.2337/dc09-1203
- By:
- Publication type:
- Article